Press Releases Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-14 pm EDT			5-day change	1st Jan Change
8.81 ^USD	+1.38%		-0.79%	+226.30%

Jun. 12	Eliem Therapeutics, Inc. Appoints Aoife Brennan as Chief Executive Officer	CI
Jun. 12	Eliem Therapeutics, Inc. Announces Management Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm	Apr. 15	PR
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders	Apr. 11	BU
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement	Apr. 11	GL
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives	23-07-20	GL
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives	23-07-20	AQ
Eliem Therapeutics : Corporate Presentation – May 2023	23-05-11	PU
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights	23-05-11	GL
ELIEM THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	23-03-16	AQ
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-03-06	AQ
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-06	AQ
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights	23-03-06	GL
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights	23-03-06	GL
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-14	AQ
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition	23-02-09	GL
ELIEM THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	23-01-24	AQ
ELIEM THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	22-12-20	AQ
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference	22-11-30	GL
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Results and Operations (form 10-Q)	22-11-14	AQ
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Press Releases

Filters